Physician profile
Claire Smart
NPI 1497786891
$1,349.77
in general payments reported to CMS, 2019-2025
17 companies · $554 in 2025
The $554 reported for 2025 was more than what 96% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $121 · 2022: $430 · 2023: $149 · 2024: $95.64 · 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $318.93 | 2022-2023 | |
| Hologic Sales and Service, LLC | $242.60 | 2022-2025 | Aptima, Thinprep 2000 Processor, Affirm Prone Biopsy System |
| Abbvie INC. | $163.84 | 2021-2025 | |
| Heron Therapeutics, INC. | $124.46 | 2025 | Zynrelef, Aponvie |
| Baxter Healthcare | $102.17 | 2025 | Perclot |
| Aspira Women'S Health INC | $75.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.18 | 2022-2025 | |
| Daiichi Sankyo INC. | $41.93 | 2022 | |
| Evofem Biosciences, INC. | $37.01 | 2022-2025 | Solosec, Phexx, Phexxi |
| Exeltis, USA INC. | $33.56 | 2022-2024 | Slynd |
| Astellas Pharma US INC | $28.29 | 2025 | Veozah |
| Becton, Dickinson and Company | $27.96 | 2023-2024 | Bd Onclarity |
| Organon LLC | $27.09 | 2024 | |
| Shield Therapeutics INC | $19.96 | 2023 | Accrufer |
| Agile Therapeutics, INC. | $18.23 | 2023 | Twirla |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $17.42 | 2025 | Femlyv |
| Coopersurgical, INC. | $16.14 | 2024 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claire Smart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.